OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2023
(3)
2021
(2)
2022
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination.
Not available
S-EPMC4749542
|
biostudies-literature
Cite
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Not available
S-EPMC10071839
|
biostudies-literature
Cite
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Not available
S-EPMC10746705
|
biostudies-literature
Cite
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Not available
S-EPMC10009825
|
biostudies-literature
Cite
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.
Not available
S-EPMC8552693
|
biostudies-literature
Cite
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981
|
biostudies-literature
Cite
Mapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets